|
Market Closed -
Nasdaq
16:00:00 2026-08-18 EDT
|
5-day change | 1st Jan Change | ||
| 1.930 USD | +6.63% |
|
-8.10% | -73.78% |
| 08-13 | Karyopharm Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 08-13 | Karyopharm Therapeutics Inc., Q2 2026 Earnings Call, Aug 13, 2026 |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +6.63% | -8.10% | -79.71% | -72.97% | -73.78% | -65.47% | -92.25% | -97.28% | -98.35% | 43.78M | |
| +0.53% | +1.66% | +19.74% | +28.67% | +4.97% | +41.18% | -0.27% | +27.48% | +97.20% | 80.91B | |
| -1.10% | -4.85% | +9.67% | +10.46% | -9.68% | -3.14% | +29.15% | +0.28% | - | 50.13B | |
| -0.23% | -2.30% | -8.95% | -7.75% | -9.18% | +12.57% | +165.89% | +118.23% | +203.16% | 47.97B | |
| +5.49% | +20.25% | +35.78% | +68.69% | -3.57% | -26.17% | -37.62% | -45.03% | +54.31% | 53.62B | |
| +1.63% | +4.25% | +3.18% | +10.76% | +20.77% | +56.39% | -18.61% | -37.83% | -32.17% | 31.41B | |
| -2.33% | +3.95% | +1.84% | +30.87% | +113.50% | +124.14% | -38.04% | -84.21% | - | 25.14B | |
| -0.02% | +1.98% | +5.30% | +29.71% | +25.01% | +45.40% | +92.80% | +65.64% | +62.12% | 25.03B | |
| +1.66% | +2.83% | +6.22% | +22.81% | +28.85% | +0.51% | +215.41% | +46.21% | - | 21.45B | |
| +0.32% | +4.77% | +0.65% | +7.27% | +40.02% | +66.79% | +127.10% | +160.19% | +371.66% | 16.93B | |
| +3.87% | -0.86% | +1.97% | +27.04% | +8.48% | +69.28% | +188.93% | +70.64% | - | 16.22B | |
| -5.10% | -9.01% | +40.11% | +8.36% | -13.82% | -11.85% | +777.46% | +498.30% | +6,146.99% | 14.69B | |
| +0.53% | -3.68% | +12.42% | +34.87% | +12.72% | +16.63% | -24.77% | -11.32% | -28.37% | 12.97B | |
| -0.27% | -0.04% | -6.22% | -5.15% | +18.10% | +94.09% | +204.73% | +962.51% | +2,806.87% | 11.3B | |
| -0.87% | +1.76% | -6.21% | +14.08% | +35.00% | +127.49% | +178.74% | +509.90% | - | 9.85B | |
| -6.68% | -5.70% | +23.71% | +133.18% | +266.02% | +314.35% | +496.61% | +18.59% | - | 7.28B | |
| -0.67% | -3.96% | +2.76% | +5.84% | -9.57% | -21.75% | -27.79% | -54.74% | -49.96% | 6.79B | |
| -2.21% | -2.54% | +12.93% | +32.88% | +6.63% | +14.10% | +75.48% | -2.73% | - | 6.41B | |
| -0.92% | +0.92% | +9.69% | +8.27% | +17.66% | +26.32% | +278.06% | +263.55% | - | 6.42B | |
| +0.39% | +2.17% | +24.30% | +48.19% | +92.70% | +135.74% | +372.59% | +560.22% | - | 6.2B | |
| Average | +0.03% | -0.31% | +5.46% | +21.80% | +28.54% | +50.83% | +148.18% | +148.43% | +866.68% | 22.54B | |
| Weighted average by Cap. | +0.48% | +1.35% | +11.38% | +25.04% | +17.66% | +36.09% | +91.36% | +81.34% | +492.88% |
- Stock Market
- Stocks
- KPTI Stock
- Sector Karyopharm Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
